Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Masimo Corporation - Common Stock (NQ: MASI )

166.09 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Where Masimo Stands With Analysts
Within the last quarter, Masimo (NASDAQ:MASI) has observed the following analyst ratings: 
Via Benzinga
Medical Pioneer Masimo Announces the Full Market Consumer Release of the Masimo W1™, the First Watch to Offer Accurate, Continuous Health Data
From Masimo
Via Business Wire
Citigroup Slashes Price Target On This Stock By 83%; Also Check Out Some Other Big PT Changes
RBC Capital cut the price target for Nuvei Corporation (NASDAQ: NVEI) from $80 to $60. Nuvei shares fell 21.5% to close at $33.03 on Tuesday. 
Via Benzinga
Masimo Clocks 85% Jump In Quarterly Sales, Provides Q3 Guidance Below Expectations
Via Benzinga
7 Analysts Have This to Say About Masimo
Masimo (NASDAQ:MASI) has observed the following analyst ratings within the last quarter: 
Via Benzinga
Masimo Posts Better Than Expected Q1 Earnings Despite 'Unexpected' Supply Chain Issues
Via Benzinga
Supply Chain Challenges To Hit Masimo's Q1 FY22 Sales
Via Benzinga
Masimo Reports Second Quarter 2022 Financial Results
From Masimo
Via Business Wire
Masimo to Report Second Quarter 2022 Financial Results after Market Close on Tuesday, August 9
From Masimo
Via Business Wire
Randomized Controlled Study Finds Masimo SedLine® Brain Function Monitoring Can Help Guide Anesthesia in Children Undergoing Minor Surgery
From Masimo
Via Business Wire
7 Best High-Growth Stocks for Young Investors
The best high-growth stocks for young investors are poised to outperform once again once the markets turn positive. 
Via InvestorPlace
Why Jim Cramer Recommends Buying Norwegian Cruise Line
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Norwegian Cruise Line Holdings Ltd. (NYSE... 
Via Benzinga
Two-part Study Finds That Remote Patient Monitoring with Masimo SafetyNet® Reduced Length of Hospital Stay for COVID-19 Patients
From Masimo
Via Business Wire
New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients
From Masimo
Via Business Wire
Masimo's Return on Invested Capital Insights
According to Benzinga Pro, during Q1, Masimo (NASDAQ:MASI) earned $46.59 million, a 31.74% increase from the preceding quarter. Masimo's sales decreased to $304.24 million, a 7.12% change since Q4. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers 
Via Benzinga
Masimo Reports First Quarter 2022 Financial Results
From Masimo
Via Business Wire
Masimo's Earnings Outlook
Masimo (NASDAQ:MASI) is set to give its latest quarterly earnings report on Tuesday, 2022-05-03. Here's what investors need to know before the announcement. Analysts estimate that Masimo will report an... 
Via Benzinga
Medical Monitoring Pioneer Announces the Limited Market Release of the Masimo W1™ Watch for Consumers
From Masimo
Via Business Wire
Masimo SedLine® Brain Function Monitoring Reduced the Use of Anesthetic Agents and Opioids in a Study on Patients Undergoing Cardiac Surgery
From Masimo
Via Business Wire
New JAMA Article Highlights the Outcome and Safety Benefits of Remote Patient Monitoring During the Pandemic and Beyond
From Masimo
Via Business Wire
Masimo Closes Acquisition of Sound United
From Masimo
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022
Upgrades 
Via Benzinga
10 Biggest Price Target Changes For Thursday
Goldman Sachs raised the price target on Consolidated Edison, Inc. (NYSE: ED) from $65 to $83. Consolidated Edison shares rose 0.5% to trade at $95.24 on Thursday. 
Via Benzinga
The Daily Biotech Pulse: Amylyx Announces Negative Adcom Vote, Clovis Jumps On Ovarian Cancer Data, Masimo Warns Of Q1 Shortfall
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Masimo Announces Certain Preliminary First Quarter 2022 Financial Results and Reaffirms Full-Year 2022 Revenue Guidance
From Masimo Corporation
Via Business Wire
New Study Finds That Noninvasive and Continuous Hemoglobin Improved Transfusion Management and Outcomes in Pediatric Patients
From Masimo
Via Business Wire
Analyst Ratings For Masimo
Analysts have provided the following ratings for Masimo (NASDAQ:MASI) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings... 
Via Benzinga
Masimo Debuts Telehealth for Patient SafetyNet™ at HIMSS 2022 Global Health Conference
From Masimo
Via Business Wire
Masimo's SedLine Brain Function Monitor Sensor Scores FDA Approval For Pediatric Use
The FDA has FDA cleared Masimo Corp's (NASDAQ: MASI) SedLine brain function monitoring for pediatric patients (1-17 years of age) and the SedLine Pediatric EEG... 
Via Benzinga
< Previous 1 2
...
12 13 14 15 16 17 18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.